Sequential therapy with topical clobetasol for 14days followed by hydroquinone versus hydroquinone alone in facial melasma treatment: a randomized, double‐blind, controlled clinical trial

BackgroundClobetasol has demonstrated remarkable results in treating melasma within a short time frame; however, its use is limited because of the risk of local side effects. To date, there is no controlled trial on sequential clobetasol/hydroquinone for melasma. This study aimed to investigate the...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	International journal of dermatology 2024-09, Vol.63 (9), p.1221-1226
Hauptverfasser:	de Amorim, Rebecca P, Barbosa, Mayla M C, Cassiano, Daniel P, Esposito, Ana C C, Dias, Marina O, Ana F T de Abreu, Bagatin, Ediléia, Miot, Hélio A
Format:	Artikel
Sprache:	eng
Schlagworte:	Atrophy Clinical trials Colorimetry Dermatitis Effectiveness Evaluation Hydroquinone Luminosity Quality of life Side effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!